Terminally Ill Patients in Two States May Bypass FDA to Access Experimental Drugs

Two states may soon join 13 others in passing so-called right-to-try bills, which would give terminally ill patients access to experimental drugs not yet approved for the market by the Food and Drug Administration.

The governors of Oklahoma and North Dakota will decide soon on the legislation.

House Bill 1074 was headed to Gov. Mary Fallin’s desk in Oklahoma, and had yet to be received by her office as of late Wednesday, according to a spokesman for the governor, who said that the bill would be reviewed once it was received.

Fallin will have five days from when it reaches her office, excluding Sunday, to review the bill, the spokesman said. Fallin will then decide to approve or veto the legislation.

The Oklahoma Right to Try Act was sponsored in the House by State Rep. Richard Morrissette (D.) and in the Senate by State Sen. Rob Standridge (R.), a pharmacist.

The legislation would allow doctors to prescribe medicines being used in clinical trials to terminally ill patients.